re: steady riser...... Yeah they were also advising CAZ more recently. But they keep saying to hold onto BAS and wait for 0.69.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
